Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1347-1360

  Azam, L ^a   Chen, Y ^b   Leslie, F M ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adolescent; fetal; maternal smoking; nicotine; sex; striatum

Indexed keywords

DOPAMINE; MESSENGER RNA; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR ALPHA6; RECEPTOR SUBUNIT; TRITIUM; UNCLASSIFIED DRUG;

ADOLESCENT; ADULTHOOD; AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MATURATION; CELL STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; GENE EXPRESSION REGULATION; GESTATION PERIOD; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NERVE ENDING; NEUROTRANSMITTER RELEASE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; UPREGULATION; VENTRAL TEGMENTUM;

AGING; ANIMALS; ANIMALS, NEWBORN; CORPUS STRIATUM; DOPAMINE; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; NEURONS; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRESYNAPTIC TERMINALS; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RNA, MESSENGER; SEX CHARACTERISTICS; SUBSTANTIA NIGRA; UP-REGULATION; VENTRAL TEGMENTAL AREA;

EID: 33846314737     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.11.011     Document Type: Article

References (78)

1. Adriani W., Spijker S., Deroche-Gamonet V., Laviola G., Le Moal M., Smit A.B., and Piazza P.V. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23 (2003) 4712-4716
2. Ajarem J.S., and Ahmad M. Prenatal nicotine exposure modifies behavior of mice through early development. Pharmacol Biochem Behav 59 (1998) 313-318
3. Andersen S.L., and Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 24 (2000) 137-141
4. Andersen S.L., Thompson A.P., Krenzel E., and Teicher M.H. Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology 27 (2002) 683-691
5. Aubert I., Cecyre D., Gauthier S., and Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. J Comp Neurol 369 (1996) 31-55
6. Azam L., and McIntosh J.M. Effect of novel alpha-conotoxins on nicotine-stimulated [3H]dopamine release from rat striatal synaptosomes. J Pharmacol Exp Ther 312 (2005) 231-237
7. Azam L., Winzer-Serhan U.H., Chen Y., and Leslie F.M. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol 444 (2002) 260-274
8. Bayer S.A., Wills K.V., Triarhou L.C., and Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp Brain Res 105 (1995) 191-199
9. Bertrand D., Valera S., Bertrand S., Ballivet M., and Rungger D. Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 2 (1991) 277-280
10. Beyer C., Pilgrim C., and Reisert I. Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids. J Neurosci 11 (1991) 1325-1333
11. Bullock A.E., Clark A.L., Grady S.R., Robinson S.F., Slobe B.S., Marks M.J., and Collins A.C. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem 68 (1997) 2412-2423
12. Castellanos F.X. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr (Phila) 36 (1997) 381-393
13. Chambers R.A., Taylor J.R., and Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160 (2003) 1041-1052
14. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., and Changeux J.P. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23 (2003) 7820-7829
15. Charpantier E., Barneoud P., Moser P., Besnard F., and Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport 9 (1998) 3097-3101
16. Chen D., and Patrick J.W. The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit. J Biol Chem 272 (1997) 24024-24029
17. Cheronis J.C., Erinoff L., Heller A., and Hoffmann P.C. Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons. Brain Res 169 (1979) 545-560
18. Clarke P.B., and Reuben M. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol 117 (1996) 595-606
19. Corrigall W.A., Franklin K.B., Coen K.M., and Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107 (1992) 285-289
20. Cox K.H., DeLeon D.V., Angerer L.M., and Angerer R.C. Detection of mRNAs in sea urchin embryos by in situ using asymmetric RNA probes. Dev Biol 101 (1984) 485-502
21. Dowell C., Olivera B.M., Garrett J.E., Staheli S.T., Watkins M., Kuryatov A., Yoshikami D., Lindstrom J.M., and McIntosh J.M. Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors. J Neurosci 23 (2003) 8445-8452
22. Drisdel R.C., and Green W.N. Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. J Neurosci 20 (2000) 133-139
23. Elliott K.J., Jones J.M., Sacaan A.I., Lloyd G.K., and Corey-Naeve J. 6-Hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression. J Mol Neurosci 10 (1998) 251-260
24. Emmett S.R., and Greenfield S.A. Correlation between dopaminergic neurons, acetylcholinesterase and nicotinic acetylcholine receptors containing the alpha3- or alpha5-subunit in the rat substantia nigra. J Chem Neuroanat 30 (2005) 34-44
25. Engele J., Pilgrim C., and Reisert I. Sexual differentiation of mesencephalic neurons in vitro: effects of sex and gonadal hormones. Int J Dev Neurosci 7 (1989) 603-611
26. Erinoff L., and Heller A. Functional ontogeny of nigrostriatal neurons. Brain Res 142 (1978) 566-569
27. Everett S.A., Warren C.W., Sharp D., Kann L., Husten C.G., and Crossett L.S. Initiation of cigarette smoking and subsequent smoking behavior among U.S. high school students. Prev Med 29 (1999) 327-333
28. Fung Y.K. Postnatal behavioural effects of maternal nicotine exposure in rats. J Pharm Pharmacol 40 (1988) 870-872
29. Fung Y.K. Postnatal effects of maternal nicotine exposure on the striatal dopaminergic system in rats. J Pharm Pharmacol 41 (1989) 576-578
30. Fung Y.K., and Lau Y.S. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol Biochem Behav 33 (1989) 1-6
31. Gerzanich V., Wang F., Kuryatov A., and Lindstrom J. alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors. J Pharmacol Exp Ther 286 (1998) 311-320
32. Grady S., Marks M.J., Wonnacott S., and Collins A.C. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59 (1992) 848-856
33. Imperato A., Mulas A., and Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132 (1986) 337-338
34. Klink R., de Kerchove d'Exaerde A., Zoli M., and Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21 (2001) 1452-1463
35. Kulak J.M., McIntosh J.M., Yoshikami D., and Olivera B.M. Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. J Neurochem 77 (2001) 1581-1589
36. Labarca C., Schwarz J., Deshpande P., Schwarz S., Nowak M.W., Fonck C., Nashmi R., Kofuji P., Dang H., Shi W., Fidan M., Khakh B.S., Chen Z., Bowers B.J., Boulter J., Wehner J.M., and Lester H.A. Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci U S A 98 (2001) 2786-2791
37. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., and Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog Brain Res 73 (1988) 137-157
38. Lichtensteiger W., and Schlumpf M. Prenatal nicotine exposure: biochemical and neuroendocrine bases of behavioral dysfunction. Dev Brain Dysfunction 6 (1993) 279-304
39. Marchand R., and Poirier L.J. Isthmic origin of neurons of the rat substantia nigra. Neuroscience 9 (1983) 373-381
40. Marshall D., Soliakov L., Redfern P., and Wonnacott S. Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology 35 (1996) 1531-1536
41. Matsubayashi H., Amano T., Seki T., Sasa M., and Sakai N. Postsynaptic alpha 4 beta 2 and alpha 7 type nicotinic acetylcholine receptors contribute to the local and endogenous acetylcholine-mediated synaptic transmissions in nigral dopaminergic neurons. Brain Res 1005 (2004) 1-8
42. Matsubayashi H., Inoue A., Amano T., Seki T., Nakata Y., Sasa M., and Sakai N. Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons. Brain Res Mol Brain Res 129 (2004) 1-7
43. McIntosh J.M., Azam L., Staheli S., Dowell C., Lindstrom J.M., Kuryatov A., Garrett J.E., Marks M.J., and Whiteaker P. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors. Mol Pharmacol 65 (2004) 944-952
44. Millberger S., Biederman J., Faraone S.V., Chen L., and Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?. Am J Psychiatry 153 (1996) 1138-1142
45. Miller J.A., and Zahniser N.R. The use of 14C-labeled tissue paste standards for the calibration of 125I-labeled ligands in quantitative autoradiography. Neurosci Lett 81 (1987) 345-350
46. Muneoka K., Ogawa T., Kamei K., Muraoka S., Tomiyoshi R., Mimura Y., Kato H., Suzuki M.R., and Takigawa M. Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res 102 (1997) 117-126
47. Naeff B., Schlumpf M., and Lichtensteiger W. Pre- and postnatal development of high-affinity [3H]nicotine binding sites in rat brain regions: an autoradiographic study. Brain Res Dev Brain Res 68 (1992) 163-174
48. Navarro H.A., Seidler F.J., Whitmore W.L., and Slotkin T.A. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther 244 (1988) 940-944
49. Nisell M., Nomikos G.G., and Svensson T.H. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 76 (1995) 157-162
50. Ovtscharoff W., Eusterschulte B., Zienecker R., Reisert I., and Pilgrim C. Sex differences in densities of dopaminergic fibers and GABAergic neurons in the prenatal rat striatum. J Comp Neurol 323 (1992) 299-304
51. Paradiso K., Sabey K., Evers A.S., Zorumski C.F., Covey D.F., and Steinbach J.H. Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells. Mol Pharmacol 58 (2000) 341-351
52. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego, CA
53. Perry D.C., and Kellar K.J. [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther 275 (1995) 1030-1034
54. Pidoplichko V.I., DeBiasi M., Williams J.T., and Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390 (1997) 401-404
55. Pliszka S.R., McCracken J.T., and Maas J.W. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 35 (1996) 264-272
56. Prince R.J., Fernandes K.G., Gregory J.C., Martyn I.D., and Lippiello P.M. Modulation of nicotine-evoked [3H]dopamine release from rat striatal synaptosomes by voltage-sensitive calcium channel ligands. Biochem Pharmacol 52 (1996) 613-618
57. Rapier C., Lunt G.G., and Wonnacott S. Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterisation. J Neurochem 54 (1990) 937-945
58. Reisert I., and Pilgrim C. Sexual differentiation of monoaminergic neurons: genetic or epigenetic?. Trends Neurosci 14 (1991) 468-473
59. Ribary U., and Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J Pharmacol Exp Ther 248 (1989) 786-792
60. Richardson S.A., and Tizabi Y. Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways. Pharmacol Biochem Behav 47 (1994) 331-337
61. Robinson L.A., and Klesges R.C. Ethnic and gender differences in risk factors for smoking onset. Health Psychol 16 (1997) 499-505
62. Schlumpf M., Gahwiler M., Ribary U., and Lichtensteiger W. A new device for monitoring early motor development: prenatal nicotine-induced changes. Pharmacol Biochem Behav 30 (1988) 199-203
63. Sharples C.G., Kaiser S., Soliakov L., Marks M.J., Collins A.C., Washburn M., Wright E., Spencer J.A., Gallagher T., Whiteaker P., and Wonnacott S. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci 20 (2000) 2783-2791
64. Simmons D.M., Arriza J.L., and Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J Histotechnol 12 (1989) 169-181
65. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse?. J Pharmacol Exp Ther 285 (1998) 931-945
66. Soliakov L., Gallagher T., and Wonnacott S. Anatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomes. Neuropharmacology 34 (1995) 1535-1541
67. Sorenson E.M., Shiroyama T., and Kitai S.T. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience 87 (1998) 659-673
68. Spear L. Modeling adolescent development and alcohol use in animals. Alcohol Res Health 24 (2000) 115-123
69. Specht L.A., Pickel V.M., Joh T.H., and Reis D.J. Fine structure of the nigrostriatal anlage in fetal rat brain by immunocytochemical localization of tyrosine hydroxylase. Brain Res 218 (1981) 49-65
70. Tizabi Y., Popke E.J., Rahman M.A., Nespor S.M., and Grunberg N.E. Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors. Pharmacol Biochem Behav 58 (1997) 141-146
71. Valera S., Ballivet M., and Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 89 (1992) 9949-9953
72. Voorn P., Kalsbeek A., Jorritsma-Byham B., and Groenewegen H.J. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25 (1988) 857-887
73. Winzer-Serhan U.H., and Leslie F.M. Codistribution of nicotinic acetylcholine receptor subunit alpha3 and beta4 mRNAs during rat brain development. J Comp Neurol 386 (1997) 540-554
74. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 20 (1997) 92-98
75. Wooltorton J.R., Pidoplichko V.I., Broide R.S., and Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23 (2003) 3176-3185
76. Yin R., and French E.D. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res Bull 51 (2000) 507-514
77. Zoli M., Le Novere N., Hill Jr. J.A., and Changeux J.P. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci 15 (1995) 1912-1939
78. Zoli M., Moretti M., Zanardi A., McIntosh J.M., Clementi F., and Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22 (2002) 8785-8789